| |
|
|
| |
EVENT DETAILS |
With applications across imaging & diagnostics, virtual assistants, remote monitoring, in-hospital care, chronic disease management, to diagnoses, precision medicine & many more - the AI healthcare space has seen a record rate of new companies entering the space every quarter. In their recent reports, CB Insights, a Future Labs graduate, highlighted healthcare as a leading category for AI investments with over 270 deal in the category since 2012 (link), a testament to the opportunities & reason for excitement in the space.
The rise of AI in healthcare can be linked to several unique factors but at the core, there are three main reasons, healthcare companies have the availability of rich data sets, there are real, quantifiable benefits to integrating AI into healthcare, & the various sectors in healthcare are ripe & open to innovation.
We'll be joined by some the leading healthcare experts & researchers from industry, academia, & startups to discuss the short-term expectations & long-term opportunities.
Confirmed Presenters:
Thomas Clozel, Co-Founder & CEO of Owkin
"Thomas Clozel, MD, a clinical research doctor & former assistant professor in clinical hematology in biology. In 2016, OWKIN passed the proof-of-concept phase & is now providing it's innovative algorithms to several of the largest pharamaceutical companies & cancer centers in Europe. With offices in New York & Paris, & France. we pride ourselves in building a company culture around fun, collaboration, challenge & optimism." - Owkin.com
Catherine Ulrich, Managing Director of FirstMark Capital
Catherine invests in a broad range of consumer & enterprise start-ups. She has a deep passion for & expertise in health & wellness, consumer AI, & behavior change. Prior to joining FirstMark, she was the Chief Product Officer at Shutterstock (NYSE: SSTK), which she joined after serving as Chief Product Officer of Weight Watchers (NYSE: WTW).
Catherine holds an AB in Engineering & a certificate in Public Health Policy from Harvard College
Dr. Daniel K. Sodickson, MD, PhD, Professor, Department of Radiology at NYU Langone Health | Department of Neuroscience & Physiology
As Vice-Chair for Research in the Department of Radiology, Daniel has overseen the development of a multifaceted translational imaging research program. This has culminated in the founding of our Center for Advanced Imaging Innovation & Research (CAI2R), which has operated since 2014 as an NIH Biomedical Technology Resource Center funded by the National Institute for Biomedical Imaging & Bioengineering. CAI2R develops novel imaging technologies for the improved management of cancer, musculoskeletal disease, & neurological disease, employing a unique new model for interdepartmental & academic-industrial collaboration to translate those technologies rapidly into clinical practice. In addition to ongoing work on rapid imaging & RF field interactions with tissue, one cornerstone of CAI2R research involves exploiting connections between imaging modalities such as MRI & PET (e.g. taking advantage of a combined MR-PET scanner operating in our Center), so as to advance the fundamental capabilities of each. The overarching goal in CAI2R is to change the paradigms of data acquisition, image reconstruction, & day-to-day scanning in biomedical imaging, for the benefit of patients & the physicians who care for them.
Abhishek Chandra (YC 2016), Co-Founder & CTO of Spring Health
Spring Health is anonline mental health clinic that is using Big Data & Measurement-Based Care to help patients feel better faster. Featured in Forbes 30 under 30 as a consumer tech entrepreneur, Abhishek is using engineering & design to disrupt the painful process of receiving effective psychiatric care. Spring's patented R&D & technical framework, published in eminent statistical & psychiatric journals, creates an integrated framework for screening, treatment selection, telemedicine & progress tracking for mental health. Prior to this, Abhishek worked with YCombinator startup PatientBank, & on the Search Infrastructure team for Google.
Dr. Osamah Choudhry, MD Founder of MediVis
Osamah Choudry is the co-founder & CEO of MediVis. Before startingMedivishe was aResident Physician in Neurological Surgery at NYU Langone Medical Center.
Summit Agenda:
5:00 - 5:30 pm - Registration5:30 - 6:00 pm - Startup Presentations6:00 - 6:30 pm - Drinks, Food,& Connecting6:30 - 6:55 pm -1st Chain Panel-The Data Challenge in Healthcare6:55 - 7:20 pm - 2nd Keynote - Investing in the Future of Healthcare7:25 - 7:40 pm -Keynote7:45 - 8:00 pm - Closing out
8:30 - 8:00 pm - Connecting
|
|
|
|
|
|
